In conclusion, our study demonstrated that abnormal expression of the autophagy-related regulator Ambra1 affected the cyclin D1 level and interfered with the sensitivity of MCL cells to the CDK4/6 inhibitor palbociclib. The gene discussed is AMBRA1; the disease is mantle cell lymphoma.